Fingerprint
Dive into the research topics of 'A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A next-generation sequencing-based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations
Mark J. Levis*, Alexander E. Perl, Jessica K. Altman, Christopher D. Gocke, Erkut Bahceci, Jason Hill, Chaofeng Liu, Zhiyi Xie, Andrew R. Carson, Valerie McClain, Timothy T. Stenzel, Jeffrey E. Miller
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
69
Scopus
citations